US 7,588,773 B2
	Methods and compositions for diagnosing and preventing a group B streptococcal infection
Linda Jeannine Brady, Gainesville, Fla. (US); Kyle N. Seifert, Harrisonburg, Va. (US); Elisabeth E. Adderson, Memphis, Tenn. (US); and John F. Bohnsack, Salt Lake City, Utah (US)
Assigned to St. Jude Children's Research Hospital, Memphis, Tenn. (US); University of Florida, Gainesville, Fla. (US); and University of Utah Research Foundation, Salt Lake City, Utah (US)
Appl. No. 11/574,067 PCT Filed Aug. 19, 2005, PCT No. PCT/US2005/029521 § 371(c)(1), (2), (4) Date Jun. 01, 2007, PCT Pub. No. WO2006/137838, PCT Pub. Date Dec. 28, 2006.
Claims priority of provisional application 60/604095, filed on Aug. 24, 2004.
Prior Publication US 2008/0039386 A1, Feb. 14, 2008
Int. Cl. A61K 39/09 (2006.01); C07K 14/315 (2006.01); C07H 21/04 (2006.01); C12P 21/04 (2006.01); C12N 15/00 (2006.01)

U.S. Cl. 424—244.1  [424/184.1; 530/350; 435/69.7; 435/320.1; 536/23.7]

2 Claims

1. An isolated serine-rich repeat protein-2 (Srr-2) or ε protein, wherein said protein comprises SEQ ID NO:2 or a fragment comprising at least 10 amino acid residues of SEQ ID NO:2.